Breast Neoplasms: all 12,820 studies
Page 94 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Shave Margins in Breast Conservation TherapyTerminatedNCT02462200Phase 2
- 2-weeks of Adjuvant Radiotherapy in Patients With Breast CancerCompletedNCT02460744Phase 2
- Acupuncture Prevents Chemobrain in Breast Cancer PatientsCompletedNCT02457039Not applicable
- Tissue Procurement Protocol for Patients Undergoing Treatment for Early-Stage Breast CancerTerminatedNCT02455882
- Feasibility and Identification of Breast Cancer Patients for Potential Avoidance of SurgeryActive, not recruitingNCT02455791Not applicable
- Traditional Chinese Medicine as Preventive Method for Osteoporosis Induced by Adjuvant Endocrine TherapyCompletedNCT02455154Phase 2
- Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast CancerActive, not recruitingNCT02455141Phase 3
- High-Intensity Interval Training for Stage I-III Breast Cancer PatientsTerminatedNCT02454777Not applicable
- Oncoplastic Approach to Excisional Breast BiopsiesCompletedNCT02452333Not applicable
- Genetic Counseling for Breast Cancer Survivors (GC for BC)CompletedNCT02451735Not applicable
- Adjuvant FEC Versus EP in Breast Cancer (MIG5)CompletedNCT02450058Phase 3
- Re-Examination of Tumor Material and Re-Evaluation of Patient Data From Patients Treated With Neo-adjuvant TherapyCompletedNCT02449993
- MRI and Early Decision-making in Chemotherapy for Breast CancerCompletedNCT02449824
- Study of Palbociclib and Trastuzumab With Endocrine Therapy in HER2-positive Metastatic Breast CancerCompletedNCT02448420Phase 2
- Topical Doxepin for Radiation-induced DermatitisStatus unknownNCT02447211Phase 2
- SOLTI Breast Cancer Molecular Screening Program (AGATA)CompletedNCT02445482
- Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR InhibitorCompletedNCT02444390Not applicable
- Laser Therapy for the Prevention of Radiodermatitis in Breast Cancer PatientsCompletedNCT02443493Not applicable
- A Study to Determine the Safety and Tolerability of Herceptin as an Adjuvant Therapy of Early Breast CancerCompletedNCT02443467
- Eribulin Use for the Treatment of Advanced Breast Cancer: A Prospective Observational RegistryCompletedNCT02443428
- Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer DiagnosticsStatus unknownNCT02441972Phase 1
- Carboplatin in EARLY Triple Negative Breast Cancer Trial (PEARLY Trial)Status unknownNCT02441933Phase 3
- Halaven Post-Marketing Surveillance (PMS)CompletedNCT02441764
- Cardiac Toxicity in Medical Treatment of Breast CancerCompletedNCT02440620
- Safety of OFS Combined With AI Endocrine Therapy in Chinese Premenopausal Breast Cancer PatientsCompletedNCT02440230Phase 2
- Risk Factors for Medium-term Adverse Outcomes and Predictive Modeling for Breast Cancer PatientsCompletedNCT02439554
- Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or BevacizumabActive, not recruitingNCT02436993Phase 2
- The Effect of Walking on Fatigue During Radiotherapy in Breast Cancer Patients 65 and OlderCompletedNCT02434367Phase 2
- Physical Activity Intervention on Myocardial Function in Patients With HER2 + Breast CancerTerminatedNCT02433067Not applicable
- Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast CancerCompletedNCT02432950Not applicable
- Radiofrequency-Guided Localization in Patients With Abnormal Breast Tissue Undergoing LumpectomyWithdrawnNCT02432118Not applicable
- Study of Preservation of Ovarian Reserve During Chemotherapy for Young Breast Cancer PatientsActive, not recruitingNCT02430103
- Effects of a Group Residential Retreat on Cancer OutcomesWithdrawnNCT02429544Not applicable
- A Multi Centre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Standard of Care Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia in Early Stage Breast Cancer (React-G Study)CompletedNCT02428114
- Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients With Persistent Triple-Negative Breast Cancer Following Neoadjuvant ChemotherapyWithdrawnNCT02427581Phase 1
- Improving Diagnosis of Breast Cancer by Using a Combined MRI and Positron Emission Mammography (MRI-PEM) SystemTerminatedNCT02426489Not applicable
- Safety of Herceptin/Trastuzumab in Metastatic Breast CancerCompletedNCT02424682
- Evaluation of a Physical Activity Program in Overweight Breast Cancer PatientsCompletedNCT02424292
- PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast CancerCompletedNCT02423603Phase 2
- Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Chemotherapy Containing DoxorubicinCompletedNCT02423356
- A Study of Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+Metastatic Breast Cancer Who Have Prior Received Anthracyclin, Taxane or TrastuzumabStatus unknownNCT02422199Phase 1/2
- Inflammation-Induced CNS Glutamate During Breast Cancer TreatmentCompletedNCT02421978
- Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesTerminatedNCT02419495Phase 1
- Poziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed RegimensCompletedNCT02418689Phase 2
- Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced CancerCompletedNCT02418624Phase 1
- Safety and Efficiency of γδ T Cell Against Breast Cancer(Her-, er-, and pr-)CompletedNCT02418481Phase 1/2
- Targeting the Hippo Transducer TAZ in Breast Cancer With StatinsStatus unknownNCT02416427Phase 2
- Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal TherapyTerminatedNCT02414776Phase 1
- Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen MesothelinActive, not recruitingNCT02414269Phase 1/2
- Investigation of Diagnostic Improvement Gained Through Optimization of MR Methods for Breast Cancer DetectionCompletedNCT02411760
- Preoperative Study With Trastuzumab, Pertuzumab and Letrozole in Breast Cancer Patients Sensitive to Hormonal TherapyCompletedNCT02411344Phase 2
- [18F]FES PET/CT in Endocrine Refractory Breast CancerTerminatedNCT02409316Phase 2
- Breast Cancer - Anti-Progestin Prevention Study 1CompletedNCT02408770Phase 2
- PatientCareAnywhere Internet-Based Software in Improving Communication and Education in Patients With Cancer and Their Healthcare ProvidersCompletedNCT02408406Not applicable
- MIRs03: Paravertebral Block With Ropivacaine Before Breast Cancer SurgeryCompletedNCT02408393Phase 3
- Effectiveness of Home-based Exercise in Quality of Life and Physical Fitness in Older Woman in Breast Cancer TreatmentCompletedNCT02408133Not applicable
- A Home-based Physical Activity Intervention in Breast Cancer SurvivorsCompletedNCT02408107Phase 3
- Efficacy of MR-HIFU Ablation of Breast CancerWithdrawnNCT02407613Not applicable
- Effect of Kinesiotaping for the Treatment of Hormone-induced Myalgia in Women Given Breast Cancer SurvivorsCompletedNCT02406794Phase 1/2
- Trial of BKM120/Tamoxifen-combination in Patients With HR-pos, HER2-neg Breast CancerCompletedNCT02404844Phase 2
- Eribulin as 1st Line Treatment in Elderly Patients With Advanced Breast CancerTerminatedNCT02404506Phase 2
- Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast CancerStatus unknownNCT02404051Phase 3
- Trial Comparing Perioperative Care for Breast Cancer Patients at a Patient Hotel vs a General Surgical WardCompletedNCT02403973Not applicable
- Quality of Life in Metastatic Breast Cancer (MBC) Patients in Second Line MonochemotherapyCompletedNCT02403869
- Auricular Acupressure for Chemotherapy-Induced Nausea and Vomiting in Female Breast Cancer PatientsCompletedNCT02403037Not applicable
- Phase IIIb Study to Evaluate the Safety and Tolerability of Herceptin SC With Perjeta and Docetaxel in Patients With HER2-positive Advanced Breast CancerCompletedNCT02402712Phase 3
- POSNOC - A Trial Looking at Axillary Treatment in Early Breast CancerActive, not recruitingNCT02401685Not applicable
- Efficacy of IORT With CT-Guided HDR Brachytherapy for Treatment of Breast CancerActive, not recruitingNCT02400658Not applicable
- Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal WomenCompletedNCT02400567Phase 2
- The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)Active, not recruitingNCT02400190Not applicable
- Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast CancerCompletedNCT02400060Not applicable
- Combination of Carboplatin, Eribulin Mesylate, and E7449 in BRCA-Related CancersWithdrawnNCT02396433Phase 1/2
- Dose-confirmation Study of ASLAN001 Combined With Weekly Paclitaxel and Carboplatin in Advanced Solid Tumours, Followed by a Study in Patients With Stage I-III HER2 Positive Breast CancerStatus unknownNCT02396108Phase 1/2
- A Study of Clinical Outcomes for the NanoString® Technologies Prosigna™ Gene Signature AssayCompletedNCT02395575
- Overcoming Endocrine Resistance in Metastatic Breast CancerStatus unknownNCT02394496Phase 3
- Human Epidermal Growth Factor Receptor 2 (HER2) Positive Unresectable Locally Advanced or Metastatic Breast Cancer Disease Registry StudyCompletedNCT02393924
- IBCSG Trial 22-00 Serum SubstudyTerminatedNCT02393833Not applicable
- Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)Active, not recruitingNCT02393794Phase 1/2
- Retroprospective Real Life Observatory of EribulinCompletedNCT02393287
- A Pilot Dose Escalation Trial of a Densified Chemotherapy Association of Docetaxel and Epirubicin Driven by Mathematical Modeling in Metastatic Breast Cancer Patients: The MODEL1 StudyCompletedNCT02392845Phase 1
- Safety, Immunogenicity and Pharmacokinetics of SYN004 in Patients With Solid TumorsCompletedNCT02391727Phase 1
- Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing SurgeryCompletedNCT02391194Phase 1
- Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combination With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast CancerCompletedNCT02390427Phase 1
- PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclibCompletedNCT02389842Phase 1
- Comparison of Intra-operative Radiotherapy With Post-operative Radiotherapy for Women With Ductal Carcinoma in SituStatus unknownNCT02389699Not applicable
- Intra-operative Radiotherapy For Breast Cancer Women After NSMStatus unknownNCT02389686Not applicable
- Dose EScalation Induction of EvERolimusCompletedNCT02387099Phase 2
- Assessment of Automated Breast UltrasoundCompletedNCT02386176
- Phase I Study of the Combination of MLN9708 and FulvestrantTerminatedNCT02384746Phase 1
- Fulvestrant as Maintenance Therapy After First-line Chemotherapy in HER2 - Postmenopausal MBC PatientsStatus unknownNCT02383030Phase 3
- An Early Phase Clinical Trial to Evaluate the Feasibility of CEST MRI in Patients With Early Stage Breast CancerTerminatedNCT02380209Early Phase 1
- A Trial of a New Magnetic Breast Marking ClipTerminatedNCT02378558Not applicable
- Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image QualityCompletedNCT02378337
- Evaluation of Oral Care to Prevent Oral Mucositis in ER Positive MBC Patients Treated With Everolimus: Phase 3 RCTCompletedNCT02376985Phase 3
- Oncoplastic Breast-conserving Surgery in Non-metastatic Breast Cancer PatientsWithdrawnNCT02376413
- Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: WBI Versus APBITerminatedNCT02375048Phase 2
- Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive SurgeryWithdrawnNCT02372305Phase 4
- Post-Marketing Surveillance Study of Eribulin on the Status and Factors for the Development of Peripheral Neuropathy in Japan.CompletedNCT02371174
- Node Negative, Invasive Breast Cancer Single Fraction IOERTActive, not recruitingNCT02370797Not applicable
- Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast CancerCompletedNCT02370277